Artist/Emergency Physician/Manufacturing Engineer/Investor in NWBO Co-owner META Collective Media, Sailor, Captain SV Catsulo. Not an investment advisor. At all
$NWBO well, as I’ve always said, I don’t believe in coincidence; Silence, deliberately withstanding a short attack, holding off the ASM until they have “something to say”. It obviously wasn’t the Journal, we already know we’ll get mfg. approval and submit MAA, so….
$NWBO People don’t understand the weight of what just occurred. As a Physician I can now send a patient’s frozen tumor to Sawston as well as a Leukapheresis. A “treating Physician” in the UK signs off for the Specials Program. the patient’s vaccine dose shipped to me, I inject it
@NYinLA2121
It’s even worse when you follow how Deutsche Bank lent him money. Laundering Russian Oligarch (mob) money through his properties. Funny how the former CEO of Deutsche Bank ended up in Cyprus eh?
$NWBO the magnitude of this PR should not be underestimated. They’ve pulled off the perfect heist against BP. Scalable in modular form as demand grows. No need for a giant plant in anticipation. But the patent is even better.
$NWBO We’ll get approved based upon the mOS and the long tail of 13% at 5 years, an almost triple over SOC. When you look at rGBM it’s even better. The Oncologists in the room were amazed. The guy next to me actually gasped.
$NWBO I’m going to, once again, make it clear I’m an NWBO shareholder and have been so since 2006. I’ve ridden through this trial for almost 17 years and understand thoroughly what has transpired, why, and how. This is revolutionary and will be fast tracked. Guarantee
$NWBO A source has indicated that Ms. Posner eviscerated Citadel’s defense today. Should pave the way for the next steps in management’s PR schedule in my perspective. Perhaps KG’s Law Firm’s recent hire was more about offsetting loss than winning?
$NWBO If anyone’s incapable of comprehending this take away one thing; what’s being shown here is the pivot toward how ALL disease will be treated and cured; all solid tumors, blood cancers, autoimmunity, viruses… incredible. Brilliance.
$NWBO This is quite a stunning paper, pre-print yes, but still quite revealing and not just because of the crazy OS; it shows a very important circulating T Cell interaction that appears to prevent and/or reactivate exhausted T Cells
$NWBO All roads are leading not only to our technology of vaccines for all solid cancers but also to Dendritic cells as the centerpiece of ALL immune modulation. Research coming in hot and guess who holds the key stone to automated manufacturing of DCs?
$NWBO Remember this is the ONLY facility with this capability and approval in the UK and maybe in Europe. Giddy up! If you don’t understand how big this is you’re not doing the homework. MHRA signaling marketing approval with this.
I’m a front line Emergency Physician. I’m an investor in a small biotech that I believe has a platform that will be on par with how Penicillin changed the world and save hundreds of millions from death around the world. Learn the story of $NWBO , they’ll be slaying giants soon
I can’t stress how huge this is! $NWBO had to submit, and gain approval for, their plan to investigate DCVax for pediatric patients by law before the could submit MAA. They got MHRA approval using the same SAP as the adult trial. Bingo!
$NWBO Remember that the ONLY reason we’re at .30 instead of the reasonable value of
#FlaskWorks
+
#DCVax
+ In licensed pipeline from Roswell + Sawston = $6-$9 is because of evidence the Southern District of NY has already seen. That MTD is toast. Soon.
$NWBO After some homework; We now have our first Institutional Investor, brokered by a legit Broker/Dealer with recent deals between $3 million and $1.3 billion. A backstop has been put in place and new capital now vetted for any nefarious ties.
$NWBO some really good things spoken of in the K this evening. Read section 7 and then look at the last sentence here; the tumor, too big to take completely out, REGRESSED with the vaccine. This is really, really important!
$NWBO
#DCVax
to all the Physicians and Clinical Researchers who’re chiming in on the P3 trial. Please read the SAP in supplement 1. If you don’t know the details quit making critiques; there are nefarious forces trying to kill this advancement
$NWBO Astute BP will be knocking on the door; someone with firepower could take a $40 billion valuation to $80-$100 bn in 2 years. From there it’s all up, up, up. LP guided FlaskWorks tech to be done more cost effectively than anyone here comprehends; margin is huge
$NWBO Linda Powers wrote the patents, re-tooled the MAA, developed the manufacturing base and the ability to scale. And she developed a great working relationship with the soon to be Nobel Laureate Dr Liau. The game is over and the fun soon to begin in earnest.
@JonKakaley
@biggercapital
After reading the NATURE article, I must say that I greatly appreciate the decision to have patented
#DCvax
-L almost everywhere in the world. Also, knowing that Dr. Liau sits on the SAB eliminates any possible competition.
$NWBO
$NWBO this company is about to explode onto the map beyond a small group who dug deep enough to comprehend what they have. Dave Innes has been freed up to create bunts, singles to left field, and even walks leading up to the home run hitter coming up to bat
$NWBO I believe we’re on the cusp of big things. Recent Nature article confirms for all that
#DCVax
technology is for real. I believe by year’s end we’ll be looking at an entirely different company and the lean days will be long gone.
$NWBO UK first, Canada, all the while small 20-30 patient trials at a handful of sites for Ovarian, Prostate, Colorectal, Breast, etc. start showing Durable Response pushes FDA to more quickly approve DCVax, followed by approvals of these additional indications + combos
$NWBO one last thing for tonight; in 2015 we were at $12.75 and had a market cap of $2.23 billion with MUCH less actual valuable pieces like an in licensed pipeline, FlaskWorks, patents, a successful P3, manufacturing license, etc. When this goes, which it will, it will explode
$NWBO optimization of FlaskWorks is at hand. One needs to understand that BP are not innovators, they partner with it. Scaling a personalized vaccine that brings the price down to $50K and can be given in a Physician’s office or rural clinic makes this a treatment for all
$NWBO wrap it up:
#DCVax
will be approved by all Regulatory Authorities. It’s time has come and it can’t be stopped. They tried, they failed. Relax, allow the process to work. This will be a time remembered in history forever. THE MARKET: ignorance reverses instantaneously.
$NWBO MAA; approved quickly. Canada soon after. Mfg optimization + global distribution = revenues beyond UK/Canada. New trials for expanded indications and combos produce quick data that FDA will use as support to approve. See beyond your nose and the long road at least widens
$NWBO has beat the system. They’ve done what no BP could do with 100’s of millions X’s the $$. MIA/MAA, combo trials, etc. Foundation solid, science exquisite. Don’t fall for anything distracting you from this fact
$NWBO careful study of the PR shows some incredible detail; complete isolation of DCs by adherence and then the subtlety of partial maturity by that adhesion. But the real beauty is gently shaking them loose with zero harm. BP locked out by the brilliant broad patent
$NWBO keep in mind the optimized FlaskWorks device is NOT a process change so the requirements for certification are not difficult to do. The device mimics every step in the man made version. The 12 Xs efficiency plus less space plus less costly and scarce lab techs= Astonishing
$NWBO New FDA Draft Guidance for using adjuvant data as confirmatory to ONE clinical trial for FDA approval. I find this part particularly interesting. Add this to the timing of the Liau paper and her appointment to the SAB…
@laurenboebert
It doesn’t take much to retrofit a pizza oven. And New Yorkers will do it because they actually care about small things that can help the environment because it’s an important issue. You rolling your eyes and making it political doesn’t change the fact that pollution harms us.
$NWBO BB is not lying about his connections; all former top dogs in BP (this is not hyperbole. I know who they are), and they know, like I do, that
#DCVax
will now be the “go to” therapy for GBM and then all solid tumors, viruses, autoimmune disease
$NWBO The very people who created a biotech from scratch, completed a P3 trial, had it published in JAMA, created and refined mfg., got it approved, created astonishing patents, and is on the verge of getting approved by multiple RAs are being treated like shit. STOP!
$NWBO LP has vision. We now own 2 types of DC vaccine technology that can be commercialized with FlaskWorks. Probably others coming. Then we can out license FlaskWorks worldwide with our Vaccines for manufacturers/distributors. Let others do the grunt work, stay nimble
$NWBO the shorts are out in full force, don’t be fooled by disinformation.
#DCVax
will be applied for in the UK and Canada through their Fast Track process. That guarantees 150 day answer, and most likely faster. DCVax is available to all who can pay. Period. It’s a done deal
$NWBO
#DCVax
In case anyone is so caught up in their money/investment, read up on
@ThomasOwenMcCa1
he beat Glioblastoma, yes, beat it because of this treatment. His son gets to grow up with his loving dad
Today is my Son’s 9th Birthday 🎂, I wouldn’t have been here to celebrate had it not been for the DCVax-L & Dr. Linda Liau , Dr. Timothy Cloughesy. And all the wonderful people
@UCLANeuros82197
You saved my Life, & I’m full of Gratitude.
@LisainNJUSA
@apwriter
@metacollectiveG
$NWBO LP has them by the balls. They know it. She outplayed them and they just can’t figure out how to save face and do what they need to do to use
#DCVax
Watch what happens and understand; if you’ve been here a while you were right
$NWBO Remember; while we waited for submission, waited for MIA approval, and while we wait for MHRA approval this company built a production capability, grew an in licensing program, & built new trials based on exceptional data by Dr. Liau. The value of these are not secret.
$NWBO I can smell it. The guys putting up 120K shares to dump the SP every day between 11:30 am and 1:30 pm are getting more desperate. Now just who do you think they’re fooling? I’d say T minus 10-14 days now. When the time comes make em pay. Be Eddie and Dan in Trading Places
$NWBO SNO abstract. The name Murcidencel is the international brand name they applied for and had approved by WHO and probably FDA. FDA approves as part of marketing approval. I don’t believe in coincidence. Ever.
$NWBO We will beat MMs. I believe we’ll see at least a couple hundred million immediately when first 3 just fold. What LP has done on fumes will suddenly be explosive with that cash. FlaskWorks $2 bn, in the UK/Canada market. Squeeze like what rocketed $TSLA. All before year end
$NWBO clarified (MHRA) that the renewal was needed to keep treating patients until a commercial authorization is signed off on. It appears they did both inspections at the same time. Full auth has a bit more paperwork. Likely soon; won’t give one and snub the other
$NWBO My thoughts for the next 3 months; 1. Something that makes Institutions buy in, creating 2. Up list to NYSE American 3. New trials Ovarian/Prostate + Poly ICLC, Colorectal with Merck’s German Subsidiary 4. MHRA approval 5. Revenue. Then another 6 mo; trial readouts/FDA app.
$NWBO
#ASCO2022
I’m looking forward to see what Oncologists think of the P3 TLD. As investors most of us are almost experts on this technology by now but remember, most Oncologists find out about these breakthroughs at big conferences like this. It’s where word of mouth begins
$NWBO Now the Supreme Court weighs in on Spoofing; If anyone thinks the fire hasn’t started they’re not looking in the right places. If an investor can’t comprehend the insidious movement of what’s occurring they’re not good investors
$NWBO Here’s the thing: everyone is missing that this is a lock and falling prey to every move of the needle day to day. You’re excited we go up 12% thinking “something must be up!” We drop, “Oh shit, what’s wrong?!” Have faith in what you know, you’re not wrong. Relax.
$NWBO I wonder what else is coming? I believe there’s more to the story beyond a JA and MHRA mfg. approval/MAA acceptance. Preferred C shares still hanging around out there ya know. Between BPs and Investment Banks there must be a lot of salivation going on. Let the games begin
$NWBO Kevin Duffy came from Merck, did some spying, went back to Merck, and is now with Regeneron who bought Checkmate and it’s Toll Like Receptor 9 Agonist. Dr. Liau presented data at Pitt showing 50% survival at 10 years with
#DCVax
plus TLR agonist. Just thinking…
$NWBO It appears the MHRA just surprised us all! They typically do not tell anyone in advance of when they’re approving things (remember the company was surprised when they changed the clinical trials website without telling anyone?) So, enjoy!
@MHRAgovuk
thanks!
#DCVax
I diagnosed GBM in 2 patients in the past 3 months. The look in their eyes and the faces of their family is incomparable; they know what they’re in for. Now I can tell them something really good is almost here. We have to be relentless in this message
$NWBO Poly ICLC doesn’t work on it’s own or with other standard therapies in combination. Why it works with
#DCVax
is why DCVax will be the control center for all future solid cancers, probably moving into other non solid CA, viruses, etc.
$NWBO Everyone needs to forget about the negative garbage, it will pass. The big issue is that clinicians are over the moon about this, as well as patient advocacy groups who have amazing influence. I know we’re invested but we need to focus on patients, all else will follow.
$NWBO well, well, well now. I would suggest there’s a disclosure obligation to an upcoming material event…. I wonder what 3rd parties, hmmm, cough, uh…
$NWBO I think we have a squeeze coming that will be epic. I believe also that whatever cards management is holding will be put on the table before December 6th. Let’s see what happens…
$NWBO I’m an investor. I make no bones about that. But DCVax was ahead of it’s time and hung in there because of LP and LG’s vision and tenacity. Love them or hate them they stood their ground. FDA is working towards them. They see it
$NWBO If anyone is even remotely worried about this AF moron just read this exchange between one of the renowned Neurosurgeons on the
#DCVax
JAMA-O article and this idiot’s logic (let alone the “failed” trial). NWBO Derangement Syndrome NWDS. Poor dumb thing
@jamesrwelchjr
That’s awesome. But it’s one story in many that don’t have that same happy ending. Your mother was never forced to abort you, she had the choice. But now other young women, without the young man with the same commitment, are being forced to carry a child
$NWBO it appears the issue of NICE not approving
#DCVax
for at least 18 months after commercial approval has turned into a game of Telephone. The company has been in communication since 2016. It will be swift. Don’t listen to uninformed people
$NWBO Well, the overall reaction in the Medical/Oncology field is overwhelmingly positive to the
#DCVax
P3 trial results. If you didn’t know there’d be some controversy you don’t know the world of Academic Medicine.
#GBM
is universally fatal, quickly. This will be approved. 100%
$NWBO Dr Liau’s work is beyond the imaginations of most of her peers; while others are trying to dazzle with the latest obscure micro pathway geeking on their trails through the trees she’s developing the highways her work will use to see and redevelop the forest. Join her
$NWBO It’s always been
#DCVax
just in case these short fools still think there are enough naive shareholders out there. It’s coming, and will be approved.
I want to be clear; I’m going to NYAS conference 5/10 specifically because it’s my understanding Dr Liau will be talking about the P3 trial of
#DCVax
$NWBO
@apwriter
@HenryMuney
@biggercapital
$NWBO “there’re two kinds of Glioblastoma tumors, bad ones and really bad ones. The bad give you 14-18 months, the others kill you in a year or less. Dead.”
#DCVax
will be approved, the FDA may have some politics in it’s dealings but it’s not deep enough to prevent this approval
$NWBO Allowance = proven to be patentable. Next step is Granted. Notice the wording “for cancer or infectious disease”. FlaskWorks and all IP is owned now by NWBO. Remember also Dr Bosch and the FW team are not sitting around being idle. There’s much more than GBM on track
$NWBO I believe something has changed fundamentally. It appears to me the look of the company has changed in the view of the broader market. I believe there are things cooking on 3 different fronts; hard to keep under cover when new factions are becoming involved.
$NWBO MAA submission is the kickoff to this platform’s potential. They got here on grit and determination like most people will never comprehend. Legend in the making
How $NWBO is revolutionizing the healthcare industry?
✔️Breadth and depth of Tx strategies
✔️Unlocking the community and removing the need for an ATC
✔️Addressing the challenge of tumor heterogeneity in solid tumors with proteomic and T cell studies
#dcvax
$NWBO it’s not uncommon for a stock to start being pushed down just prior to a series of big changes that blow it up. The most sophisticated and sturdy make money on other’s emotions. “The process is the Product”. This is the key to your success as an investor here. Think.
1/2 $NWBO Dr. Bosch’s presentation was a quiet K-Boom! In my opinion regarding T cell recruitment, activation, etc. But in particular one needs to comprehend T cell exhaustion in Cancers and in chronic viral infections (age and kill us). The clonal expansion found with DCVax
$NWBO the immune system is primitive as fuck, but sophisticated & adaptive. The human brain functions to study this and improve upon it in real time. Dr. Liau and Al Boynton saw it and had the “Eureka” moment of all time. DCs are the company commanders reacting to various inputs
$NWBO by the way, DCVax-L trial had only 7 out of 331 patients with IDH-1 mutation (a now known beneficial mutation for survival) In the Optune trial $NVCR had almost 50% IDH-1 mutation. Let’s think hard about these issues please and keep focused. We have approvable data here.
$NWBO Dear Big Pharma. Dear Wall Street; just give them their due. They pulled it off and it’s been crazily epic in their fight against you. They won. Kiss them
$NWBO
#DCVax
PR out on the news wire. Read the entire article and especially read the SAP in supplement 1. It’s the exact roadmap that Pazdur used in his article in support of external controls. This is the icing on the cake and signals FDA approval.
$NWBO That was solid. I find it amazing what they’ve accomplished and where we are, and how poised we are for approvals; “strategically” set. It feels like a well oiled corporation pushing forward and in command
$NWBO Sophisticated retail investors who do well dig deep. To the average retail looking for an edge, read this from the top 3 authors of the JAMA-O publication in response to a critic. If you don’t understand what this is buy a mutual fund, you’re not ready
$NWBO I believe we’re all here because we saw something extraordinary. Extraordinary often has to take tangled paths and so drag us through it with them. I’m with them to the end. I know what we have and what patients need. Im as emotional as anyone, but logic wins
$NWBO I love they’ve been methodical without hyperbolic PRs, tweets, etc. They’ve told us exactly what they’ve been working on and announced them when accomplished. So many believed they’d never get published (AF). There’ll be controversy, as always. But we won. It’s Cancer ffs
$NWBO the squeeze is on; a small biotech defying the odds/manipulation. The science is solid and their manufacturing is the best kept secret in the market
$NWBO I’m getting private messages everywhere asking if they’re still pursuing Journal after TLD! Guys, please settle down. This is how it’s done. TLD is a statement; “we met our primary and secondary endpoints of…” The details come in peer reviewed details. It’s coming!
$NWBO LP built infrastructure ‘quietly’. I kept saying it. The intrinsic value upon approval has vastly increased compared to before. Now add in more trials including cervical/prostate/colorectal/Direct/pediatric, again quietly, the intrinsic value after approval = much more.
$NWBO Denial of MTD. MHRA approval. 120 million revenues begins 2025 with first 500 patients while ramp up of FlaskWorks. 3 x P2 trials @ no cost. Direct starts. Peds trials start. Who else got in licensed? Combo trials. Wall Street’s big reveal. The machine finally engaged.
$NWBO There’s a crack in the short position and the water is starting to turn from a trickle. I think they now understand there’s not going to be a large dilutive raise before MHRA approval. They don’t want to spark a squeeze… shhhhhhh